Optimisation By Platform Trial Involving Multiple Interventions With Simultaneous Evaluation In Community Acquired Pneumonia (OPTIMISE-CAP)
Funder
National Health and Medical Research Council
Funding Amount
$4,413,145.00
Summary
In Australia severe Community Acquired Pneumonia is responsible for more than 7000 ICU admissions and 1400 deaths each year. This trial will determine the optimal treatments among existing choices of therapy related to choice of antibiotic, ventilator strategy and modulation of the immune system. The trial uses new methods to answer more research questions as quickly as possible.